Literature DB >> 26612221

Diagnosis of Bladder Carcinoma: A Clinician's Perspective.

Lauren C Harshman1, Mark A Preston2, Joaquim Bellmunt3, Clair Beard4.   

Abstract

In 2014, more than 74,000 new cases and 15,000 deaths from bladder cancer were estimated to occur. The most reliable prognostic factors for survival are pathologic stage and histologic grade. Accordingly, a good understanding of the pathologic features of these cancers is essential to guide optimal clinical treatment, which requires a multidisciplinary team of pathologists, urologists, radiation oncologists, and medical oncologists. This review highlights several clinical scenarios in which detailed pathologic evaluation and accurate reporting impact clinical management.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Histologic variants; Nonmetastatic muscle-invasive bladder cancer; Non–muscle-invasive bladder cancer

Mesh:

Year:  2015        PMID: 26612221     DOI: 10.1016/j.path.2015.07.004

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  5 in total

1.  Physical activity patterns and associations with health-related quality of life in bladder cancer survivors.

Authors:  Ajay Gopalakrishna; Thomas A Longo; Joseph J Fantony; Michael R Harrison; Brant A Inman
Journal:  Urol Oncol       Date:  2017-05-17       Impact factor: 3.498

2.  Lipid-Rich Variant of Urothelial Carcinoma Presenting as the Dominant Morphology in a Recurrent Tumor After Local Therapy.

Authors:  Archi Patel; Rowena E Velilla; Muhammad Salah Shurbaji
Journal:  Am J Case Rep       Date:  2018-04-23

Review 3.  Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.

Authors:  Maria Lucia Iacovino; Chiara Carmen Miceli; Marco De Felice; Biagio Barone; Luca Pompella; Francesco Chiancone; Erika Di Zazzo; Giuseppe Tirino; Carminia Maria Della Corte; Ciro Imbimbo; Ferdinando De Vita; Felice Crocetto
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 4.  The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment.

Authors:  Vincenzo Cuccurullo; Giuseppe Danilo Di Stasio; Francesco Manti; Pierpaolo Arcuri; Rocco Damiano; Giuseppe Lucio Cascini
Journal:  Diagnostics (Basel)       Date:  2021-05-11

5.  Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target.

Authors:  Ming Sun; Wenyan Zhao; Yuecan Zeng; Di Zhang; Zhaofu Chen; Caigang Liu; Bin Wu
Journal:  Onco Targets Ther       Date:  2017-08-07       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.